Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 7 |
GO:0110165 | cellular anatomical entity | 1 | 7 |
GO:0005789 | endoplasmic reticulum membrane | 4 | 1 |
GO:0031090 | organelle membrane | 3 | 1 |
Related structures:
AlphaFold database: E9AT31
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 8 |
GO:0008152 | metabolic process | 1 | 8 |
GO:0008610 | lipid biosynthetic process | 4 | 8 |
GO:0009058 | biosynthetic process | 2 | 8 |
GO:0044238 | primary metabolic process | 2 | 8 |
GO:0071704 | organic substance metabolic process | 2 | 8 |
GO:1901576 | organic substance biosynthetic process | 3 | 8 |
GO:0006694 | steroid biosynthetic process | 5 | 1 |
GO:0008202 | steroid metabolic process | 4 | 1 |
GO:0016125 | sterol metabolic process | 4 | 1 |
GO:0016126 | sterol biosynthetic process | 5 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
GO:1901362 | organic cyclic compound biosynthetic process | 4 | 1 |
GO:1901615 | organic hydroxy compound metabolic process | 3 | 1 |
GO:1901617 | organic hydroxy compound biosynthetic process | 4 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 8 |
GO:0005488 | binding | 1 | 8 |
GO:0005506 | iron ion binding | 6 | 8 |
GO:0016491 | oxidoreductase activity | 2 | 8 |
GO:0043167 | ion binding | 2 | 8 |
GO:0043169 | cation binding | 3 | 8 |
GO:0046872 | metal ion binding | 4 | 8 |
GO:0046914 | transition metal ion binding | 5 | 8 |
GO:0000254 | C-4 methylsterol oxidase activity | 5 | 1 |
GO:0004497 | monooxygenase activity | 3 | 1 |
GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 3 | 1 |
GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen | 4 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 138 | 142 | PF00656 | 0.193 |
CLV_NRD_NRD_1 | 115 | 117 | PF00675 | 0.404 |
CLV_NRD_NRD_1 | 123 | 125 | PF00675 | 0.302 |
CLV_PCSK_KEX2_1 | 115 | 117 | PF00082 | 0.362 |
CLV_PCSK_SKI1_1 | 283 | 287 | PF00082 | 0.387 |
CLV_PCSK_SKI1_1 | 375 | 379 | PF00082 | 0.593 |
CLV_PCSK_SKI1_1 | 6 | 10 | PF00082 | 0.466 |
DEG_MDM2_SWIB_1 | 316 | 324 | PF02201 | 0.308 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.575 |
DOC_CKS1_1 | 251 | 256 | PF01111 | 0.308 |
DOC_CYCLIN_yCln2_LP_2 | 148 | 154 | PF00134 | 0.354 |
DOC_MAPK_gen_1 | 2 | 10 | PF00069 | 0.564 |
DOC_PP2B_LxvP_1 | 109 | 112 | PF13499 | 0.545 |
DOC_PP2B_LxvP_1 | 148 | 151 | PF13499 | 0.363 |
DOC_PP2B_LxvP_1 | 166 | 169 | PF13499 | 0.336 |
DOC_USP7_MATH_1 | 281 | 285 | PF00917 | 0.302 |
DOC_USP7_UBL2_3 | 121 | 125 | PF12436 | 0.562 |
DOC_USP7_UBL2_3 | 2 | 6 | PF12436 | 0.675 |
DOC_WW_Pin1_4 | 250 | 255 | PF00397 | 0.302 |
LIG_14-3-3_CanoR_1 | 17 | 25 | PF00244 | 0.508 |
LIG_14-3-3_CanoR_1 | 373 | 378 | PF00244 | 0.432 |
LIG_Actin_WH2_2 | 180 | 195 | PF00022 | 0.360 |
LIG_APCC_ABBA_1 | 88 | 93 | PF00400 | 0.367 |
LIG_BRCT_BRCA1_1 | 347 | 351 | PF00533 | 0.302 |
LIG_CtBP_PxDLS_1 | 196 | 200 | PF00389 | 0.338 |
LIG_EH1_1 | 205 | 213 | PF00400 | 0.298 |
LIG_EH1_1 | 217 | 225 | PF00400 | 0.279 |
LIG_FHA_1 | 131 | 137 | PF00498 | 0.463 |
LIG_FHA_1 | 171 | 177 | PF00498 | 0.295 |
LIG_FHA_1 | 240 | 246 | PF00498 | 0.265 |
LIG_FHA_1 | 305 | 311 | PF00498 | 0.308 |
LIG_FHA_1 | 338 | 344 | PF00498 | 0.259 |
LIG_FHA_1 | 372 | 378 | PF00498 | 0.525 |
LIG_FHA_2 | 136 | 142 | PF00498 | 0.193 |
LIG_FHA_2 | 251 | 257 | PF00498 | 0.308 |
LIG_FHA_2 | 275 | 281 | PF00498 | 0.308 |
LIG_FHA_2 | 374 | 380 | PF00498 | 0.460 |
LIG_LIR_Apic_2 | 250 | 254 | PF02991 | 0.302 |
LIG_LIR_Gen_1 | 266 | 276 | PF02991 | 0.381 |
LIG_LIR_Gen_1 | 298 | 308 | PF02991 | 0.302 |
LIG_LIR_Gen_1 | 70 | 81 | PF02991 | 0.331 |
LIG_LIR_Nem_3 | 214 | 220 | PF02991 | 0.346 |
LIG_LIR_Nem_3 | 229 | 234 | PF02991 | 0.216 |
LIG_LIR_Nem_3 | 265 | 271 | PF02991 | 0.295 |
LIG_LIR_Nem_3 | 298 | 304 | PF02991 | 0.302 |
LIG_LIR_Nem_3 | 360 | 365 | PF02991 | 0.411 |
LIG_LIR_Nem_3 | 70 | 76 | PF02991 | 0.334 |
LIG_OCRL_FandH_1 | 233 | 245 | PF00620 | 0.302 |
LIG_PCNA_yPIPBox_3 | 227 | 237 | PF02747 | 0.187 |
LIG_Pex14_2 | 269 | 273 | PF04695 | 0.302 |
LIG_Pex14_2 | 316 | 320 | PF04695 | 0.302 |
LIG_Pex14_2 | 69 | 73 | PF04695 | 0.354 |
LIG_Pex14_2 | 85 | 89 | PF04695 | 0.354 |
LIG_PTB_Apo_2 | 83 | 90 | PF02174 | 0.354 |
LIG_REV1ctd_RIR_1 | 271 | 279 | PF16727 | 0.187 |
LIG_SH2_CRK | 120 | 124 | PF00017 | 0.555 |
LIG_SH2_CRK | 155 | 159 | PF00017 | 0.363 |
LIG_SH2_CRK | 251 | 255 | PF00017 | 0.259 |
LIG_SH2_STAP1 | 155 | 159 | PF00017 | 0.363 |
LIG_SH2_STAT5 | 147 | 150 | PF00017 | 0.346 |
LIG_SH2_STAT5 | 157 | 160 | PF00017 | 0.242 |
LIG_SH2_STAT5 | 218 | 221 | PF00017 | 0.259 |
LIG_SH2_STAT5 | 241 | 244 | PF00017 | 0.259 |
LIG_SH2_STAT5 | 268 | 271 | PF00017 | 0.307 |
LIG_SH2_STAT5 | 276 | 279 | PF00017 | 0.311 |
LIG_SH2_STAT5 | 30 | 33 | PF00017 | 0.354 |
LIG_SH2_STAT5 | 314 | 317 | PF00017 | 0.271 |
LIG_SH2_STAT5 | 362 | 365 | PF00017 | 0.338 |
LIG_SH2_STAT5 | 59 | 62 | PF00017 | 0.406 |
LIG_SH3_1 | 120 | 126 | PF00018 | 0.532 |
LIG_SH3_3 | 120 | 126 | PF00018 | 0.554 |
LIG_SH3_3 | 42 | 48 | PF00018 | 0.306 |
LIG_SH3_3 | 5 | 11 | PF00018 | 0.635 |
LIG_SUMO_SIM_par_1 | 131 | 138 | PF11976 | 0.388 |
LIG_TRAF2_1 | 254 | 257 | PF00917 | 0.256 |
LIG_TRAF2_1 | 277 | 280 | PF00917 | 0.308 |
LIG_TYR_ITIM | 153 | 158 | PF00017 | 0.427 |
MOD_CK1_1 | 226 | 232 | PF00069 | 0.285 |
MOD_CK2_1 | 250 | 256 | PF00069 | 0.302 |
MOD_CK2_1 | 274 | 280 | PF00069 | 0.385 |
MOD_CK2_1 | 373 | 379 | PF00069 | 0.429 |
MOD_Cter_Amidation | 113 | 116 | PF01082 | 0.352 |
MOD_GlcNHglycan | 130 | 133 | PF01048 | 0.455 |
MOD_GlcNHglycan | 141 | 144 | PF01048 | 0.305 |
MOD_GlcNHglycan | 187 | 190 | PF01048 | 0.570 |
MOD_GlcNHglycan | 20 | 23 | PF01048 | 0.276 |
MOD_GlcNHglycan | 283 | 286 | PF01048 | 0.508 |
MOD_GlcNHglycan | 288 | 291 | PF01048 | 0.537 |
MOD_GlcNHglycan | 311 | 314 | PF01048 | 0.459 |
MOD_GlcNHglycan | 347 | 350 | PF01048 | 0.502 |
MOD_GSK3_1 | 130 | 137 | PF00069 | 0.587 |
MOD_GSK3_1 | 219 | 226 | PF00069 | 0.318 |
MOD_GSK3_1 | 239 | 246 | PF00069 | 0.335 |
MOD_GSK3_1 | 281 | 288 | PF00069 | 0.324 |
MOD_LATS_1 | 371 | 377 | PF00433 | 0.386 |
MOD_N-GLC_2 | 162 | 164 | PF02516 | 0.556 |
MOD_N-GLC_2 | 342 | 344 | PF02516 | 0.508 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.654 |
MOD_NEK2_1 | 134 | 139 | PF00069 | 0.354 |
MOD_NEK2_1 | 158 | 163 | PF00069 | 0.492 |
MOD_NEK2_1 | 286 | 291 | PF00069 | 0.354 |
MOD_NEK2_1 | 295 | 300 | PF00069 | 0.265 |
MOD_NEK2_1 | 316 | 321 | PF00069 | 0.265 |
MOD_NEK2_1 | 337 | 342 | PF00069 | 0.302 |
MOD_NEK2_1 | 55 | 60 | PF00069 | 0.364 |
MOD_NEK2_1 | 91 | 96 | PF00069 | 0.590 |
MOD_PKA_2 | 274 | 280 | PF00069 | 0.187 |
MOD_Plk_4 | 130 | 136 | PF00069 | 0.529 |
MOD_Plk_4 | 170 | 176 | PF00069 | 0.296 |
MOD_Plk_4 | 219 | 225 | PF00069 | 0.303 |
MOD_Plk_4 | 226 | 232 | PF00069 | 0.296 |
MOD_Plk_4 | 24 | 30 | PF00069 | 0.296 |
MOD_Plk_4 | 316 | 322 | PF00069 | 0.302 |
MOD_Plk_4 | 36 | 42 | PF00069 | 0.314 |
MOD_Plk_4 | 55 | 61 | PF00069 | 0.455 |
MOD_ProDKin_1 | 250 | 256 | PF00069 | 0.302 |
MOD_SUMO_for_1 | 377 | 380 | PF00179 | 0.408 |
MOD_SUMO_rev_2 | 379 | 385 | PF00179 | 0.452 |
TRG_ENDOCYTIC_2 | 147 | 150 | PF00928 | 0.354 |
TRG_ENDOCYTIC_2 | 155 | 158 | PF00928 | 0.234 |
TRG_ENDOCYTIC_2 | 231 | 234 | PF00928 | 0.259 |
TRG_ENDOCYTIC_2 | 268 | 271 | PF00928 | 0.293 |
TRG_ENDOCYTIC_2 | 50 | 53 | PF00928 | 0.309 |
TRG_ER_diArg_1 | 115 | 117 | PF00400 | 0.566 |
TRG_ER_diArg_1 | 331 | 334 | PF00400 | 0.302 |
TRG_NES_CRM1_1 | 35 | 47 | PF08389 | 0.193 |
TRG_Pf-PMV_PEXEL_1 | 375 | 379 | PF00026 | 0.568 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PEE3 | Leptomonas seymouri | 58% | 100% |
A0A0S4JXU3 | Bodo saltans | 36% | 100% |
A0A3Q8IKR9 | Leishmania donovani | 88% | 100% |
A4HPC0 | Leishmania braziliensis | 75% | 98% |
A4ICG0 | Leishmania infantum | 88% | 100% |
Q4Q1G7 | Leishmania major | 86% | 100% |